Comparing lymph node removal methods for lung cancer after pre-surgery treatment
Part of Cancer, Lungs & breathing clinical trials.
This trial compares two ways of removing lymph nodes during lung cancer surgery after you've had pre-surgery immunotherapy and chemotherapy. It aims to see if taking only a few key lymph nodes (instead of all of them) is just as effective and leads to fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 74 years old.
- You have been diagnosed with non-small cell lung cancer (the most common type).
- Your cancer is at a stage when it's still in the chest and can potentially be removed with surgery (stage II or III).
- Your tumor is on the outer part of the lung (not in the center).
- You have already completed a course of immunotherapy plus chemotherapy before surgery.
- Your cancer does not have certain gene changes (EGFR or ALK) and you haven't had lung surgery on the same side before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two surgical approaches for advanced lung cancer (stage IIA-IIIB) after patients have already received immunotherapy and chemotherapy. Researchers want to see if removing a smaller portion of the lung (sub-lobectomy) works as well as removing an entire lobe (lobectomy), potentially reducing side effects while fighting cancer.
This trial tests a new approach for people with certain advanced non-small cell lung cancer (NSCLC) that has spread to lymph nodes in the chest but might still be removed. It combines a short course of high-precision radiation, immunotherapy (sintilimab), and standard chemotherapy before surgery to see if it can improve outcomes.
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This study tests a new way to decide which lymph nodes to remove during lung cancer surgery. The goal is to make surgery more precise and reduce side effects while still effectively removing cancer.
This trial compares two surgical approaches for people with a single small, noncancer-looking lung nodule (a GGN) that is diagnosed as very early lung cancer. It aims to see whether removing mediastinal lymph nodes—or leaving them alone—can lead to better outcomes with less harm.
This trial looks at complications from removing lymph nodes during surgery for non-small cell lung cancer. It may help doctors understand how to make surgery safer.
Hear when a new Stage IIA-IIIB NSCLC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.